Figure 1 .

Kaplan-Meier estimates for (A) brain PFS by hormone receptor (HR) status; (B) PFS by hormone receptor (HR) status; (C) OS by hormone receptor (HR) status; (D) brain PFS by prior capecitabine; (E) PFS by prior capecitabine; and (F) OS by prior capecitabine in patients with brain metastasis on entry.

Ro et al. BMC Cancer 2012 12:322   doi:10.1186/1471-2407-12-322
Download authors' original image